Therefore, the primary purpose of this review is to summarize the recent advances regarding the effects and related epigenetic mechanisms of SIRT1 in diabetic complications, including diabetic cardiomyopathy (DCM), diabetic nephropathy (DN), and diabetic retinopathy (DR). This evidence concerns the gene SIRT1 and liver dysplastic nodule.